TY - JOUR
T1 - A highly virulent variant of HIV-1 circulating in the Netherlands
AU - Netherlands ATHENA HIV Observational Cohort
AU - BEEHIVE collaboration
AU - Wymant, Chris
AU - Bezemer, Daniela
AU - Blanquart, François
AU - Ferretti, Luca
AU - Gall, Astrid
AU - Hall, Matthew
AU - Golubchik, Tanya
AU - Bakker, Margreet
AU - Ong, Swee Hoe
AU - Zhao, Lele
AU - Bonsall, David
AU - De Cesare, Mariateresa
AU - MacIntyre-Cockett, George
AU - Abeler-Dörner, Lucie
AU - Albert, Jan
AU - Bannert, Norbert
AU - Fellay, Jacques
AU - Grabowski, M. Kate
AU - Gunsenheimer-Bartmeyer, Barbara
AU - Günthard, Huldrych F.
AU - Kivelä, Pia
AU - Kouyos, Roger D.
AU - Laeyendecker, Oliver
AU - Meyer, Laurence
AU - Porter, Kholoud
AU - Ristola, Matti
AU - Van Sighem, Ard
AU - Berkhout, Ben
AU - Kellam, Paul
AU - Cornelissen, Marion
AU - Reiss, Peter
AU - Fraser, Christophe
N1 - Publisher Copyright:
Copyright © 2022 The Authors, some rights reserved.
PY - 2022/2/4
Y1 - 2022/2/4
N2 - We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred nine individuals with this variant had a 0.54 to 0.74 log10 increase (i.e., a ~3.5-fold to 5.5-fold increase) in viral load compared with, and exhibited CD4 cell decline twice as fast as, 6604 individuals with other subtype-B strains. Without treatment, advanced HIV - CD4 cell counts below 350 cells per cubic millimeter, with long-term clinical consequences - is expected to be reached, on average, 9 months after diagnosis for individuals in their thirties with this variant. Age, sex, suspected mode of transmission, and place of birth for the aforementioned 109 individuals were typical for HIV-positive people in the Netherlands, which suggests that the increased virulence is attributable to the viral strain. Genetic sequence analysis suggests that this variant arose in the 1990s from de novo mutation, not recombination, with increased transmissibility and an unfamiliar molecular mechanism of virulence.
AB - We discovered a highly virulent variant of subtype-B HIV-1 in the Netherlands. One hundred nine individuals with this variant had a 0.54 to 0.74 log10 increase (i.e., a ~3.5-fold to 5.5-fold increase) in viral load compared with, and exhibited CD4 cell decline twice as fast as, 6604 individuals with other subtype-B strains. Without treatment, advanced HIV - CD4 cell counts below 350 cells per cubic millimeter, with long-term clinical consequences - is expected to be reached, on average, 9 months after diagnosis for individuals in their thirties with this variant. Age, sex, suspected mode of transmission, and place of birth for the aforementioned 109 individuals were typical for HIV-positive people in the Netherlands, which suggests that the increased virulence is attributable to the viral strain. Genetic sequence analysis suggests that this variant arose in the 1990s from de novo mutation, not recombination, with increased transmissibility and an unfamiliar molecular mechanism of virulence.
UR - http://www.scopus.com/inward/record.url?scp=85124019619&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85124019619&partnerID=8YFLogxK
U2 - 10.1126/science.abk1688
DO - 10.1126/science.abk1688
M3 - Article
C2 - 35113714
AN - SCOPUS:85124019619
SN - 0036-8075
VL - 375
SP - 540
EP - 545
JO - Science
JF - Science
IS - 6580
M1 - A30
ER -